North American Neuromodulation Society
Contains 0 items
Subtotal: $0.00

SCS Waveforms: Compared and Contrasted – Live Webinar


Date and Time

Thursday, January 7, 2021; 7:30 - 8:45 pm CST

Pricing and Registration

  • NANS Member: Free
  • Non-Member: Free

Registration Deadline: Thursday, January 7, at 7:00 pm (CST)
*Participants must register in advance to receive the webinar link. 

After purchasing the webinar, you will receive a confirmation email containing the GoToWebinar registration link. You MUST register through GoToWebinar as well to access the webinar. f you do not receive a confirmation, please contact NANS Member Services at 847.375.4714 or

Register Now


This webinar will discuss various types of waveforms and their impact on chronic pain. Faculty will provide a technological overview of neuromodulation in reference to hardware, programming, and MRI. Speakers will present on the following topics:

  • Differential Targeted Multiplexed
  • Burst
  • High Frequency 10 kHz
  • Multiwave
  • Closed-Loop

Target Audience

This webinar is designed for physicians, advanced practice providers, and fellows.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the role of waveforms in the chronic pain pathway.
  • Indicate the technological differences in neuromodulation.
  • Explain the impact on pain reduction with various uses of neuromodulation on the spinal cord.


  • Ricardo Vallejo, MD PhD (moderator)
  • Michael A. Fishman, MD MBA
  • Sandy Christiansen, MD
  • Krishnan V. Chakravarthy, MD PhD
  • Sean Li, MD


  • Steven M. Falowski, MD
  • Ahmed M. Raslan, MD




The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the NANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

Please note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the Congress of Neurological Surgeons, as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest to the program participants prior to the start of the activity. 

CNS is also required to manage any reported conflict and eliminate the potential for bias during the activity. All conflicts of interest have been resolved in accordance with ACCME’s Standards for Commercial Support.  

It is also each speaker’s responsibility to include the FDA clearance status of any device or drug requiring FDA approval discussed or described in their presentation or to describe the lack of FDA clearance for any “off label” uses discussed. 

Please find the relevant financial relationships disclosed below for all individuals in control of content. Activity Planners are designated with a (P). Planners, faculty, and any other individuals in control of content not listed have indicated that they have no relevant financial relationships to disclose for this activity.

 Name Relationship/Company 

Steven M. Falowski, MD (P)

Consulting Fee – Abbott, Boston Scientific, Medtronic, Vertiflex, Vertos
Contracted Research – Abbott, Boston Scientific, Medtronic, Stimgenics, Vertiflex
Ownership Interest (Future Stock Options) – Celeri, CornerLoc, PainTeq, Saluda Medical, SPR Therapeutics, Stimgenics, Thermaquil

Ricardo Vallejo, MD PhD Consulting Fee – Medtronic
Speaker Bureau - Medtronic
Krishnan V. Chakravarthy, MD PhD
Consulting Fee – Medtronic, Bioness, PAINTEQ, Medincell, Vivex Biologics 
Ownership Interest (Future Stock Options) – Higgs Boson Health (HBH), Oska Wellness, Nalu Medical, Mainstay Medical, Aya Biosciences
 Michael A. Fishman, MD MBA

Consulting Fee – Abbott, Biotronik, Braeburn, Cornerloc, Medtronic, Nevro
Contracted Research  – Abbott, Biotronik, Foundation Fusion Solutions, Lumbrera, Medtronic, Nalu Medical, SGX Medical, Thermaquil
Ownership Interest (Own Stocks) – Celeri Health, Thermaquil

 Sean Li, MD Consulting Fee – Abbott, Avanos, Biotronik, Boston Scientific, Gruenthal, Nalu, Nevro, Saluda, SI-Bone, Vertos
Contracted Research – Avanos, Biotronik, Boston Scientific, Nevro, Saluda, SGX Medical, SPR Therapeutics
Advisory Board – Abbott, Saluda
Ownership Interest (Own Stocks) – Nalu, National Spine and Pain Centers

Accreditation & Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Congress of Neurological Surgeons (CNS) and the North American Neuromodulation Society. The CNS is accredited by ACCME to provide continuing medical education for physicians.

The CNS designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Criteria for Successful Completion 

  • Watch live webinar
  • Achieve passing score of 70% or higher on post-test
  • Completion/submission of evaluation form

Claiming CME Credit

After the live webinar, you will be sent an email from our online reporting tool to complete a post-test and an evaluation. After passing the post-test and successfully completing the evaluation, you will be able to print and save a copy of your CME certificate.

Please note that the post-test and evaluation will only remain open until January 22, 2021. After this date, the system will not allow participants to complete the post-test or evaluation. CME credits will not be awarded to participants that fail to complete the post-test and evaluation prior to January 22, 2021.



WIKISTIM is a searchable database being populated with data published in the field of neuromodulation. The goals of WIKISTIM are to improve patient care and the quality of research reports, foster communication, reveal research needs, and support the practice of evidence–based medicine.

Upcoming Events  

  • MAY 13-15, 2021

    46th Annual Regional
    Anesthesiology & Acute Pain Medicine Meeting
    Disney's Yacht & Beach Club Resorts
    Lake Buena Vista, FL
    Learn More

  • JUNE 24-26, 2021

    NANS NIC Joint Meeting

  • JULY 15-17, 2021

    NANS Mid-Year Meeting
    Walt Disney World Swan & Dolphin Resort
    Orlando, FL

Contains 0 items
Subtotal: $0.00